author-photo

Margaret Nartea

Fred Hutchinson Cancer Research Center

9

Papers

108

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (7)
The Alpha Emitter Astatine-211 Targeted to CD38 can Eradicate Multiple Myeloma in a Disseminated Disease Model

2019 Blood
Show All
- Source
- Cite
- Save
Citations (14)
Safety and Efficacy of Yttrium-90-Labeled Anti-CD45 Antibody ( 90 Y-DOTA-BC8) Followed By a Standard Reduced-Intensity Hematopoietic Stem Cell Transplant (HCT) Regimen for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS)

2018 Blood
Show All
- Source
- Cite
- Save
Citations (3)
A Phase I Trial of 90Y-BC8-DOTA (Anti-CD45) Monoclonal Antibody in Combination with Fludarabine and TBI As Conditioning for Allogeneic Peripheral Blood Stem Cell Transplant to Treat High Risk Multiple Myeloma

2017 Blood
Show All
- Source
- Cite
- Save
Citations (3)
Safety and Activity of Brentuximab Vedotin (BV) Plus Ifosfamide, Carboplatin, and Etoposide (ICE) for Relapsed/Refractory (Rel/Ref) Classical Hodgkin Lymphoma (cHL): Initial Results of a Phase I/II Trial

2016 Blood
Show All
- Source
- Cite
- Save
Citations (32)
Venetoclax Synergizes with Radiation Therapy for Treatment of B-Cell Lymphomas

2016 Blood
Show All
- Source
- Cite
- Save
Citations (1)